APGE +45% on Acquisition
AbbVie to acquire Apogee Therapeutics, sending APGE stock up 45% premarket
Top Big Cap Positive News Movers Premarket: APGE: +45% AbbVie to Acquire Apogee Therapeutics DFTX: +38% Positive Topline Results from Phase 3 Emerge Study of DT120 ORKA: +18% Symp. off APGE Headlines UMC: +13% Form 6K Filing - To clarify news reported by Economic Daily News on June 21, 2026 MLTX: +11% Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa SYRE: +10% Symp. off APGE Headlines FRVO: +7% Earnings MU: +5% PT Raised at Needham INTC: +3% Greenstone Biosciences, Inc. and Intel Corp.
Launch Strategic Collaboration to Scale Human-Centric Drug Discovery